1 / 81

Hematologic Disorders and Cancer

Hematologic Disorders and Cancer. ACC Susan Beggs, RN MSN. Adult RBCs: 120 Lower H & H than child Lower WBCs than child . Pediatric RBCs: 100 days in neonate Increased erythropoiesis with age Higher H & H in children (17-18g) # of RBCs varies according to age.

Télécharger la présentation

Hematologic Disorders and Cancer

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Hematologic Disorders and Cancer ACC Susan Beggs, RN MSN

  2. Adult RBCs: 120 Lower H & H than child Lower WBCs than child Pediatric RBCs: 100 days in neonate Increased erythropoiesis with age Higher H & H in children (17-18g) # of RBCs varies according to age Comparison of adult to pedi hematologic system

  3. RBC Maturation • Basophilic erythroblast* • Orthochromic erythroblast* • Proerythroblast • Reticulocyte • Erythrocyte • Other cells that might be suggestive of disorders:

  4. Components of the CBC • WBCs (leukocytes) • Neutrophils • Lymphocytes • Monocytes • Eosinophils • Basophils

  5. Bands • Slighty smaller than other immature forms • Make up 0-6% of WBC count • Indicative of a shift to the left

  6. Neutrophils • Segmented (segs) • Together with the lymphocytes, make up 75-90% of peripheral blood • Elevated indicative of a shift to the left or long term infection

  7. What is peak and what is trough? • Peak refers to the effectiveness of the medication; checks saturation and penetration 30 min AFTER end of infusion • Trough check if too little or too much 30 minutes PRIOR to next dose

  8. Iron deficiency anemia

  9. Iron deficiency anemia • Causes • Diagnostic tests to confirm • Treatments

  10. Diagnostic tests to confirm IDA •  hemoglobin •  hematocrit, MCV •  serum iron, RBC • Presence of reticulocytes (immature or newly released RBCs • Changes in iron-binding capacity • Serum ferritin < 15ng/ml

  11. Treatments for IDA • Two major treatments: • Oral • Dietary teaching

  12. Sickle cell disease (SCD)

  13. Types of sickle cell crisis • Vaso-occlusive • Aplastic crisis • Splenic sequestration crisis

  14. Vaso-occlusive crises • Stasis of blood and clumping of cells in the microcirculation (capillaries) • May last from 1 day to several wks • Manifestations:

  15. SCD, continued • Manifestations: • Chronic anemia (hgb 6-9) • Fatigue • Pain in areas of ischemia (joints) • Jaundice • Possible delayed sexual maturation • Susceptibility to sepsis • Possible growth retardation

  16. What factors start the sickling? • Being submitted to hypoxia • Low blood pH (acidosis) • Increased blood viscosity • General stress • Infection

  17. Aplastic crisis • Diminished RBC production • Results in severe anemia • Manifestations: • Headache • Pallor • Lethargy • **may be precipitated by infection

  18. Splenic sequestration crisis • Sickled cells trapped in spleen • Blood flow is obstructed • Resulting in splenomegaly • May lead to : • Shock • Hypovolemia • tachycardia

  19. Diagnostic Studies for SCD • Hemoglobin electrophoresis in NB • Child > 6 months of age, quick screen (Sickledex) • CBC results: • Decreased H & H (6-9 hgb) • Elevated reticulocytes (immature RBCs)

  20. Nsg interventions for reactions to blood transfusions • Stay with patients the 1st 5-10 minutes after beginning the transfusion • STOP the blood if rx occur, but NOT the IV • Monitor VS • Listen for adventitious breath sounds that indicate overload

  21. Insuring hydration in the child with SCD • Educating parents s/s dehydration • Instructions on # oz to replace fluids lost • Understand the “triggers” and precipitating factors • Monitoring I & O • Perform regular growth and nutritional assessments

  22. Goals for SCD • Oxygenation • Adequate hydration • Pain relief • Prevention of infection • Education of child/family • No cure, but can be managed

  23. Types and causes • Hemophilia A • Most common (75%) • Disorder with factor VIII • Bleeding most common symptom • Von Wildebrand is type of this hemophilia • Hemophilia B • Disorder with factor IX

  24. Diagnostics and Treatment • Monitor studies which may be abnormal: PTT, Bleeding time, platelet counts, Factor VIII levels • Prevention and treatment of bleeding: • Protective gear for play • Limited activities • Replacement of clotting factors • Cold to cause vasoconstriction

  25. Joint changes

  26. Labs tests to confirm hemophilia • DNA testing for the trait • PTT prolonged • Bleeding time prolonged • Plt and PT are normal • Low levels of factor VIII

  27. Administering Meds for Hemophilia • Genetically engineered Factor VIII blood products; reconstituted with sterile water and given IV • Human plasma, fresh whole blood, fresh or frozen plasma (1 bag of concentrate per 5 kg of body weight is usually sufficient) • Vasopressin (DDAVP) IV

  28. Nursing goals/interventions for the hemophiliac • Prevent bleeding or STOP bleeding • **Major cause of death: hemorrhage • Apply pressure 10-15 min • Elevate the joint above the heart • Immobilize the extremity • Apply cold compresses

  29. Cancer

  30. “…communication promotes understanding and clarity; with understanding, fear diminishes; in the absence of fear, hope emerges; and in the presence of hope, anything is possible” (Stovall, 1995)

  31. Causes of childhood cancers • Unlike adults, children don’t have the environmental exposures • May be genetic? • May be viral? Immune defects? • Genome project has identified genes for some of the cancers in children

  32. Warning signs • C • H • I • L • D • R • E • N

  33. Interventions for malignancies • Radiation • Chemotherapy • Central lines (implanted ports) • Intrathecal • Steroids • Surgery • Bone marrow and stem cell transplantation

  34. Intrathecal chemotherapy

  35. Leukemias • Malignancies of the blood • Characterized by IMMATURE WBCs/blast cells • ALL most common (80%) • ANLL also common(20%)

  36. Treatments for Leukemias • Staging must be done first to determine cell types • Induction • Consolidation • Delayed intensification • Remission Maintenance

  37. Signs and symptoms that would suggest leukemia • Fever • Pallor • Overt signs of bleeding • Lethargy • Malaise • Anorexia • Large joint or bone pain • Petechiae • Hepatomegaly, lymphadenopathy, splenomegaly • Neuro findings with CNS mets

  38. Nsg interventions for chemo side effects • Myelosuppression: monitor labs, prophylactics, injury awareness • Infection/sepsis: neutropenia, visitors, protective isolation • Renal damage: I & O, hematuria • GI: nutrition maintenance, high calorie drinks, cold better than warm • Metabolic emergencies: tymor lysis

More Related